Device-Associated Infection Rates in 20 Cities of India, Data Summary for 2004–2013: Findings of the International Nosocomial Infection Control Consortium
Infection Control and Hospital Epidemiology2015Vol. 37(2), pp. 172–181
Citations Over TimeTop 10% of 2015 papers
Yatin Mehta, Namita Jaggi, Víctor Rosenthal, Maithili Kavathekar, Asmita Sagar Sakle, Nita Munshi, Murali Chakravarthy, Subhash Todi, Narinder Kumar Saini, Camilla Rodrigues, Karthikeya Varma, Rekha Dubey, Mohammad Mukhit Kazi, Farokh Udwadia, Sheila Nainan Myatra, Sweta Shah, Arpita Dwivedy, Anil Karlekar, Sanjeev Singh, Nagamani Sen, Kashmira Limaye-Joshi, Bala Ramachandran, Suneeta Sahu, Nirav Pandya, Purva Mathur, Samir Sahu, Suman Singh, Anil Kumar Bilolikar, Siva Kumar, Preeti Mehta, Vikram Padbidri, Gita Nadimpalli, Saroj Kumar Patnaik, Thara Francis, Anup Warrier, S. Muralidharan, Pravin K. Nair, Vaibhavi Subhedar, Ramachadran Gopinath, Afzal Azim, Sanjeev Sood
Abstract
Despite a lower device use ratio in our ICUs, our device-associated healthcare-associated infection rates are higher than National Healthcare Safety Network, but lower than International Nosocomial Infection Control Consortium Report.
Related Papers
- → Up or Down? Will the Real Central Line-Associated Bloodstream Infection Rate Please Step Up!(2017)1 cited
- → Accurately Predicting Risk of Central Line-Associated Bloodstream Infection—Application of Machine Learning to Predict and Minimize Incidence of Central Line-Associated Bloodstream Infection(2017)1 cited
- → Preventing Central Line Associated Bloodstream Infections in the PICU: Changing What's Possible in Infection Prevention(2012)
- The Effects of the program to prevent central line-associated bloodstream infection (CLABSI) in Medical ICU.(ผลของโปรแกรมควบคมการตดเชอในเลอดจากการคาสายสวนหลอดเลอดดำใหญ ของผปวยทเขารบการรกษาในไอซยอายรกรรม)(2018)
- → Utilizing Central Line Practice Validation to Reduce Clabsi (Central Line Associated Bloodstream Infection) Incidents on an Oncology Unit(2022)